Accordingly, ATG16L1 was down-regulated in GC-resistant patients, which might lead us to speculate that induction of autophagy might help to overcome GC-resistance in IBD patients, as it happens in leukemia. This evidence concerns the gene ATG16L1 and inflammatory bowel disease.